Darren Barton

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +5

Transplantation of discarded livers following viability testing with normothermic machine perfusion

Hynek Mergental, Richard W. Laing, Amanda Kirkham et al. · Nature Communications · 2020 · 471 citations · Full text

Medicine, Surgery, Hepatology +14

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

Matthew J. Armstrong, Diana Hull, Kathy Guo et al. · Journal of Hepatology · 2015 · 447 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Philip N. Newsome, Richard Fox, Andrew King et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 159 citations · Full text

Medicine, Hematology, Immunology +16

Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial

Richard W. Laing, Hynek Mergental, Christina Yap et al. · BMJ Open · 2017 · 115 citations · Full text

Medicine, Surgery, Perioperative Quality Improvement +15